Predictors of COVID-19 Vaccine Acceptance Among Nigerian Medical Doctors

CA Nri-Ezedi, C. Okechukwu, OC Ofiaeli, E. Nwaneli, S. Musa, I. Kida, H. Adetola, T. Ulasi
{"title":"Predictors of COVID-19 Vaccine Acceptance Among Nigerian Medical Doctors","authors":"CA Nri-Ezedi, C. Okechukwu, OC Ofiaeli, E. Nwaneli, S. Musa, I. Kida, H. Adetola, T. Ulasi","doi":"10.30442/ahr.0801-01-152","DOIUrl":null,"url":null,"abstract":"Background: Since its discovery in late 2019, COVID-19 has claimed approximately three million lives worldwide, causing a significant economic burden and strain on health care delivery and services. Therefore, the COVID-19 vaccine may offer the potential to promote global recovery. \nObjective: To determine the acceptability of the COVID-19 vaccine among Nigerian doctors and the factors influencing the acceptance. \nMethods: Using a cross-sectional design, an anonymous online survey was administered to medical doctors across the six geopolitical zones in Nigeria between 13 January and 31 January 2021, using the health belief model (HBM). \nResults: Out of 830 respondents, 38.8% were willing to take the COVID-19 vaccine, 36.0% were unsure, while the remaining 26.5% refused to take the vaccine. Following adjustments, males were more likely to take the vaccine (OR = 3.357; 95% CI 2.009-5.610; p = 0.0001), whereas increasing age, higher perceived viral virulence and perceived viral infectivity were observed to be significantly associated with less likelihood of accepting the vaccine. Respondents who believed in the efficacy of ivermectin were much less likely to receive the vaccine (OR = 0.217; 95% CI 0.108-0.436; p = 0.001). Concerns on vaccination safety were the main barriers to vaccine acceptability. Hypothetically addressing these concerns increased vaccine acceptance rates by approximately a third (34.6%) (p < 0.001). \nConclusion: The proposed nationwide distribution of the COVID-19 vaccine may be met with poor vaccine acceptability among Nigerian medical practitioners. Measures specifically addressing vaccine safety concerns should be provided to allay fears and enhance the acceptability of the vaccine.","PeriodicalId":52960,"journal":{"name":"Annals of Health Research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Health Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30442/ahr.0801-01-152","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Since its discovery in late 2019, COVID-19 has claimed approximately three million lives worldwide, causing a significant economic burden and strain on health care delivery and services. Therefore, the COVID-19 vaccine may offer the potential to promote global recovery. Objective: To determine the acceptability of the COVID-19 vaccine among Nigerian doctors and the factors influencing the acceptance. Methods: Using a cross-sectional design, an anonymous online survey was administered to medical doctors across the six geopolitical zones in Nigeria between 13 January and 31 January 2021, using the health belief model (HBM). Results: Out of 830 respondents, 38.8% were willing to take the COVID-19 vaccine, 36.0% were unsure, while the remaining 26.5% refused to take the vaccine. Following adjustments, males were more likely to take the vaccine (OR = 3.357; 95% CI 2.009-5.610; p = 0.0001), whereas increasing age, higher perceived viral virulence and perceived viral infectivity were observed to be significantly associated with less likelihood of accepting the vaccine. Respondents who believed in the efficacy of ivermectin were much less likely to receive the vaccine (OR = 0.217; 95% CI 0.108-0.436; p = 0.001). Concerns on vaccination safety were the main barriers to vaccine acceptability. Hypothetically addressing these concerns increased vaccine acceptance rates by approximately a third (34.6%) (p < 0.001). Conclusion: The proposed nationwide distribution of the COVID-19 vaccine may be met with poor vaccine acceptability among Nigerian medical practitioners. Measures specifically addressing vaccine safety concerns should be provided to allay fears and enhance the acceptability of the vaccine.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
尼日利亚医生对COVID-19疫苗接受度的预测因素
背景:自2019年末发现以来,新冠肺炎已在全球夺走约300万人的生命,给医疗保健提供和服务带来了巨大的经济负担和压力。因此,新冠肺炎疫苗可能提供促进全球复苏的潜力。目的:确定新冠肺炎疫苗在尼日利亚医生中的可接受性及其影响因素。方法:使用横断面设计,在2021年1月13日至1月31日期间,使用健康信念模型(HBM)对尼日利亚六个地缘政治地区的医生进行了匿名在线调查。结果:830名受访者中,38.8%的人愿意接种新冠肺炎疫苗,36.0%的人不确定,其余26.5%的人拒绝接种。调整后,男性更有可能接种疫苗(OR=3.357;95%CI2.009-5.610;p=0.0001),而年龄增加、感知病毒毒力和感知病毒传染性较高与接受疫苗的可能性降低显著相关。相信伊维菌素有效性的受访者接种疫苗的可能性要小得多(OR=0.217;95%CI 0.108-0.436;p=0.001)。对疫苗接种安全性的担忧是疫苗可接受性的主要障碍。假设解决这些问题使疫苗接受率提高了约三分之一(34.6%)(p<0.001)。结论:拟议的新冠肺炎疫苗全国分发可能会遇到尼日利亚医生对疫苗接受率低的问题。应提供专门解决疫苗安全问题的措施,以减轻恐惧,提高疫苗的可接受性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
0
审稿时长
20 weeks
期刊最新文献
Sonographic Correlations between Intravesical Prostatic Protrusion and Bladder Outlet Obstruction in Patients with Symptomatic Benign Prostatic Hyperplasia in Ibadan, Nigeria Medication Adherence, Barriers to Adherence and Treatment Satisfaction with Antiretroviral Therapy Among Adolescents Living with HIV in Lagos, Nigeria Diabetes-Related-Distress and its Relationship with Glycaemic Control Among Type 2 Diabetes Mellitus Patients Attending a Specialty Clinic in Lagos, Nigeria Experiences of Professional Autonomy Among Critical Care Nurses in Kenya: A Qualitative Study Decision-to-Delivery Interval and Obstetric Outcomes of Emergency Caesarean Sections in a Nigerian Teaching Hospital
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1